Discontinued — last reported Q4 '19
GE HealthCare Technologies Net Income Loss Attributable To Redeemable Noncontrolling Interest increased by 23.5% to $21.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 12.5%, from $24.00M to $21.00M. This increase may warrant attention — for this metric, lower values are generally preferred.
A significant allocation reduces the net income available to common shareholders, impacting EPS calculations.
The portion of net income or loss allocated to noncontrolling interests that have redemption features, meaning they may...
Standard financial reporting requirement for companies with complex joint venture or partnership structures.
other_net_income_loss_attributable_to_redeemable_noncont_fbb3b6| Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $9.00M | $10.00M | $5.00M | $10.00M | $11.00M | $7.00M | $11.00M | $5.00M | $19.00M | $24.00M | $13.00M | $17.00M | $21.00M |
| QoQ Change | — | +11.1% | -50.0% | +100.0% | +10.0% | -36.4% | +57.1% | -54.5% | +280.0% | +26.3% | -45.8% | +30.8% | +23.5% |
| YoY Change | — | — | — | +11.1% | +10.0% | +40.0% | +10.0% | -54.5% | +171.4% | +118.2% | +160.0% | -10.5% | -12.5% |